ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

BRCA Carriers Live Longer Than Those With Normal Gene

January 25, 2008

NIEHS Uses Gene Chips To Evaluate Chemicals.

March 3, 2000

Mihich Subcommittee Recommendations For Augmenting Agents In BRMP Described

December 7, 1979

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

NCI’s Hawk To Lead Prevention Division At M.D. Anderson.

November 16, 2007

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

December 19, 2008